Global End-Stage Kidney Disease Market Growth (Status and Outlook) 2020-2025
According to this study, over the next five years the End-Stage Kidney Disease market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in End-Stage Kidney Disease business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of End-Stage Kidney Disease market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the End-Stage Kidney Disease, covering the supply chain analysis, impact assessment to the End-Stage Kidney Disease market size growth rate in several scenarios, and the measures to be undertaken by End-Stage Kidney Disease companies in response to the COVID-19 epidemic.
Segmentation by treatment: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Transplantation
Dialysis
Segmentation by end user: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Hospital
Clinic
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Nipro Corporation
JMS Co. Ltd.
Fresenius Medical Care
Medtronic Plc
B. Braun Melsungen AG
Baxter International, Inc.
Cantel Medical
BD
Nikkiso Co., Ltd
Asahi Kasei Medical Co., Ltd.
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global End-Stage Kidney Disease market size by key regions/countries, treatment and end user, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of End-Stage Kidney Disease market by identifying its various subsegments.
Focuses on the key global End-Stage Kidney Disease players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the End-Stage Kidney Disease with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of End-Stage Kidney Disease submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global End-Stage Kidney Disease Market Size 2015-2025
2.1.2 End-Stage Kidney Disease Market Size CAGR by Region
2.2 End-Stage Kidney Disease Segment by Treatment
2.2.1 Transplantation
2.2.2 Transplantation
2.3 End-Stage Kidney Disease Market Size by Treatment
2.3.1 Global End-Stage Kidney Disease Market Size Market Share by Treatment (2015-2020)
2.3.2 Global End-Stage Kidney Disease Market Size Growth Rate by Treatment (2015-2020)
2.4 End-Stage Kidney Disease Segment by End User
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 End-Stage Kidney Disease Market Size by End User
2.5.1 Global End-Stage Kidney Disease Market Size Market Share by End User (2015-2020)
2.5.2 Global End-Stage Kidney Disease Market Size Growth Rate by End User (2015-2020)
3 Global End-Stage Kidney Disease by Players
3.1 Global End-Stage Kidney Disease Market Size Market Share by Players
3.1.1 Global End-Stage Kidney Disease Market Size by Players (2018-2020)
3.1.2 Global End-Stage Kidney Disease Market Size Market Share by Players (2018-2020)
3.2 Global End-Stage Kidney Disease Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 End-Stage Kidney Disease by Regions
4.1 End-Stage Kidney Disease Market Size by Regions
4.2 Americas End-Stage Kidney Disease Market Size Growth
4.3 APAC End-Stage Kidney Disease Market Size Growth
4.4 Europe End-Stage Kidney Disease Market Size Growth
4.5 Middle East & Africa End-Stage Kidney Disease Market Size Growth
5 Americas
5.1 Americas End-Stage Kidney Disease Market Size by Countries
5.2 Americas End-Stage Kidney Disease Market Size by Treatment
5.3 Americas End-Stage Kidney Disease Market Size by End User
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC End-Stage Kidney Disease Market Size by Regions
6.2 APAC End-Stage Kidney Disease Market Size by Treatment
6.3 APAC End-Stage Kidney Disease Market Size by End User
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe End-Stage Kidney Disease by Countries
7.2 Europe End-Stage Kidney Disease Market Size by Treatment
7.3 Europe End-Stage Kidney Disease Market Size by End User
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa End-Stage Kidney Disease by Countries
8.2 Middle East & Africa End-Stage Kidney Disease Market Size by Treatment
8.3 Middle East & Africa End-Stage Kidney Disease Market Size by End User
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global End-Stage Kidney Disease Market Forecast
10.1 Global End-Stage Kidney Disease Market Size Forecast (2021-2025)
10.2 Global End-Stage Kidney Disease Forecast by Regions
10.2.1 Global End-Stage Kidney Disease Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global End-Stage Kidney Disease Forecast by Treatment
10.8 Global End-Stage Kidney Disease Forecast by End User
11 Key Players Analysis
11.1 Nipro Corporation
11.1.1 Company Details
11.1.2 End-Stage Kidney Disease Product Offered
11.1.3 Nipro Corporation End-Stage Kidney Disease Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Nipro Corporation News
11.2 JMS Co. Ltd.
11.2.1 Company Details
11.2.2 End-Stage Kidney Disease Product Offered
11.2.3 JMS Co. Ltd. End-Stage Kidney Disease Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 JMS Co. Ltd. News
11.3 Fresenius Medical Care
11.3.1 Company Details
11.3.2 End-Stage Kidney Disease Product Offered
11.3.3 Fresenius Medical Care End-Stage Kidney Disease Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Fresenius Medical Care News
11.4 Medtronic Plc
11.4.1 Company Details
11.4.2 End-Stage Kidney Disease Product Offered
11.4.3 Medtronic Plc End-Stage Kidney Disease Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Medtronic Plc News
11.5 B. Braun Melsungen AG
11.5.1 Company Details
11.5.2 End-Stage Kidney Disease Product Offered
11.5.3 B. Braun Melsungen AG End-Stage Kidney Disease Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 B. Braun Melsungen AG News
11.6 Baxter International, Inc.
11.6.1 Company Details
11.6.2 End-Stage Kidney Disease Product Offered
11.6.3 Baxter International, Inc. End-Stage Kidney Disease Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Baxter International, Inc. News
11.7 Cantel Medical
11.7.1 Company Details
11.7.2 End-Stage Kidney Disease Product Offered
11.7.3 Cantel Medical End-Stage Kidney Disease Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 Cantel Medical News
11.8 BD
11.8.1 Company Details
11.8.2 End-Stage Kidney Disease Product Offered
11.8.3 BD End-Stage Kidney Disease Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 BD News
11.9 Nikkiso Co., Ltd
11.9.1 Company Details
11.9.2 End-Stage Kidney Disease Product Offered
11.9.3 Nikkiso Co., Ltd End-Stage Kidney Disease Revenue, Gross Margin and Market Share (2018-2020)
11.9.4 Main Business Overview
11.9.5 Nikkiso Co., Ltd News
11.10 Asahi Kasei Medical Co., Ltd.
11.10.1 Company Details
11.10.2 End-Stage Kidney Disease Product Offered
11.10.3 Asahi Kasei Medical Co., Ltd. End-Stage Kidney Disease Revenue, Gross Margin and Market Share (2018-2020)
11.10.4 Main Business Overview
11.10.5 Asahi Kasei Medical Co., Ltd. News
12 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. End-Stage Kidney Disease Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Transplantation
Table 5. Major Players of Dialysis
Table 6. End-Stage Kidney Disease Market Size by Treatment (2014-2019) ($ Millions)
Table 7. Global End-Stage Kidney Disease Market Size Market Share by Treatment (2015-2020)
Table 8. Global End-Stage Kidney Disease Market Size by End User (2015-2020) ($ Millions)
Table 9. Global End-Stage Kidney Disease Market Size Market Share by End User (2015-2020)
Table 10. Global End-Stage Kidney Disease Revenue by Players (2018-2020) ($ Millions)
Table 11. Global End-Stage Kidney Disease Revenue Market Share by Players (2018-2020)
Table 12. Global End-Stage Kidney Disease Key Players Head office and Products Offered
Table 13. End-Stage Kidney Disease Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global End-Stage Kidney Disease Market Size by Regions 2015-2020 ($ Millions)
Table 17. Global End-Stage Kidney Disease Market Size Market Share by Regions 2015-2020
Table 18. Americas End-Stage Kidney Disease Market Size by Countries (2015-2020) ($ Millions)
Table 19. Americas End-Stage Kidney Disease Market Size Market Share by Countries (2015-2020)
Table 20. Americas End-Stage Kidney Disease Market Size by Treatment (2015-2020) ($ Millions)
Table 21. Americas End-Stage Kidney Disease Market Size Market Share by Treatment (2015-2020)
Table 22. Americas End-Stage Kidney Disease Market Size by End User (2015-2020) ($ Millions)
Table 23. Americas End-Stage Kidney Disease Market Size Market Share by End User (2015-2020)
Table 24. APAC End-Stage Kidney Disease Market Size by Regions (2015-2020) ($ Millions)
Table 25. APAC End-Stage Kidney Disease Market Size Market Share by Regions (2015-2020)
Table 26. APAC End-Stage Kidney Disease Market Size by Treatment (2015-2020) ($ Millions)
Table 27. APAC End-Stage Kidney Disease Market Size Market Share by Treatment (2015-2020)
Table 28. APAC End-Stage Kidney Disease Market Size by End User (2015-2020) ($ Millions)
Table 29. APAC End-Stage Kidney Disease Market Size Market Share by End User (2015-2020)
Table 30. Europe End-Stage Kidney Disease Market Size by Countries (2015-2020) ($ Millions)
Table 31. Europe End-Stage Kidney Disease Market Size Market Share by Countries (2015-2020)
Table 32. Europe End-Stage Kidney Disease Market Size by Treatment (2015-2020) ($ Millions)
Table 33. Europe End-Stage Kidney Disease Market Size Market Share by Treatment (2015-2020)
Table 34. Europe End-Stage Kidney Disease Market Size by End User (2015-2020) ($ Millions)
Table 35. Europe End-Stage Kidney Disease Market Size Market Share by End User (2015-2020)
Table 36. Middle East & Africa End-Stage Kidney Disease Market Size by Countries (2015-2020) ($ Millions)
Table 37. Middle East & Africa End-Stage Kidney Disease Market Size Market Share by Countries (2015-2020)
Table 38. Middle East & Africa End-Stage Kidney Disease Market Size by Treatment (2015-2020) ($ Millions)
Table 39. Middle East & Africa End-Stage Kidney Disease Market Size Market Share by Treatment (2015-2020)
Table 40. Middle East & Africa End-Stage Kidney Disease Market Size by End User (2015-2020) ($ Millions)
Table 41. Middle East & Africa End-Stage Kidney Disease Market Size Market Share by End User (2015-2020)
Table 42. Key and Potential Regions of End-Stage Kidney Disease
Table 43. Key Application and Potential Industries of End-Stage Kidney Disease
Table 44. Key Challenges of End-Stage Kidney Disease
Table 45. Key Trends of End-Stage Kidney Disease
Table 46. Global End-Stage Kidney Disease Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 47. Global End-Stage Kidney Disease Market Size Market Share Forecast by Regions
Table 48. Global End-Stage Kidney Disease Market Size Forecast by Treatment (2021-2025) ($ Millions)
Table 49. Global End-Stage Kidney Disease Market Size Market Share Forecast by Treatment (2021-2025)
Table 50. Global End-Stage Kidney Disease Market Size Forecast by End User (2021-2025) ($ Millions)
Table 51. Global End-Stage Kidney Disease Market Size Market Share Forecast by End User (2021-2025)
Table 52. Nipro Corporation Details, Company Total Revenue (in $ million), Head Office, End-Stage Kidney Disease Major Market Areas and Its Competitors
Table 53. Nipro Corporation End-Stage Kidney Disease Product Offered
Table 54. Nipro Corporation End-Stage Kidney Disease Revenue and Gross Margin (2018-2020E)
Table 55. Nipro Corporation Main Business
Table 56. Nipro Corporation Latest Developments
Table 57. JMS Co. Ltd. Details, Company Total Revenue (in $ million), Head Office, End-Stage Kidney Disease Major Market Areas and Its Competitors
Table 58. JMS Co. Ltd. End-Stage Kidney Disease Product Offered
Table 59. JMS Co. Ltd. Main Business
Table 60. JMS Co. Ltd. End-Stage Kidney Disease Revenue and Gross Margin (2018-2020E)
Table 61. JMS Co. Ltd. Latest Developments
Table 62. Fresenius Medical Care Details, Company Total Revenue (in $ million), Head Office, End-Stage Kidney Disease Major Market Areas and Its Competitors
Table 63. Fresenius Medical Care End-Stage Kidney Disease Product Offered
Table 64. Fresenius Medical Care Main Business
Table 65. Fresenius Medical Care End-Stage Kidney Disease Revenue and Gross Margin (2018-2020E)
Table 66. Fresenius Medical Care Latest Developments
Table 67. Medtronic Plc Details, Company Total Revenue (in $ million), Head Office, End-Stage Kidney Disease Major Market Areas and Its Competitors
Table 68. Medtronic Plc End-Stage Kidney Disease Product Offered
Table 69. Medtronic Plc Main Business
Table 70. Medtronic Plc End-Stage Kidney Disease Revenue and Gross Margin (2018-2020E)
Table 71. Medtronic Plc Latest Developments
Table 72. B. Braun Melsungen AG Details, Company Total Revenue (in $ million), Head Office, End-Stage Kidney Disease Major Market Areas and Its Competitors
Table 73. B. Braun Melsungen AG End-Stage Kidney Disease Product Offered
Table 74. B. Braun Melsungen AG Main Business
Table 75. B. Braun Melsungen AG End-Stage Kidney Disease Revenue and Gross Margin (2018-2020E)
Table 76. B. Braun Melsungen AG Latest Developments
Table 77. Baxter International, Inc. Details, Company Total Revenue (in $ million), Head Office, End-Stage Kidney Disease Major Market Areas and Its Competitors
Table 78. Baxter International, Inc. End-Stage Kidney Disease Product Offered
Table 79. Baxter International, Inc. Main Business
Table 80. Baxter International, Inc. End-Stage Kidney Disease Revenue and Gross Margin (2018-2020E)
Table 81. Baxter International, Inc. Latest Developments
Table 82. Cantel Medical Details, Company Total Revenue (in $ million), Head Office, End-Stage Kidney Disease Major Market Areas and Its Competitors
Table 83. Cantel Medical End-Stage Kidney Disease Product Offered
Table 84. Cantel Medical Main Business
Table 85. Cantel Medical End-Stage Kidney Disease Revenue and Gross Margin (2018-2020E)
Table 86. Cantel Medical Latest Developments
Table 87. BD Details, Company Total Revenue (in $ million), Head Office, End-Stage Kidney Disease Major Market Areas and Its Competitors
Table 88. BD End-Stage Kidney Disease Product Offered
Table 89. BD Main Business
Table 90. BD End-Stage Kidney Disease Revenue and Gross Margin (2018-2020E)
Table 91. BD Latest Developments
Table 92. Nikkiso Co., Ltd Details, Company Total Revenue (in $ million), Head Office, End-Stage Kidney Disease Major Market Areas and Its Competitors
Table 93. Nikkiso Co., Ltd End-Stage Kidney Disease Product Offered
Table 94. Nikkiso Co., Ltd Main Business
Table 95. Nikkiso Co., Ltd End-Stage Kidney Disease Revenue and Gross Margin (2018-2020E)
Table 96. Nikkiso Co., Ltd Latest Developments
Table 97. Asahi Kasei Medical Co., Ltd. Details, Company Total Revenue (in $ million), Head Office, End-Stage Kidney Disease Major Market Areas and Its Competitors
Table 98. Asahi Kasei Medical Co., Ltd. End-Stage Kidney Disease Product Offered
Table 99. Asahi Kasei Medical Co., Ltd. Main Business
Table 100. Asahi Kasei Medical Co., Ltd. End-Stage Kidney Disease Revenue and Gross Margin (2018-2020E)
Table 101. Asahi Kasei Medical Co., Ltd. Latest Developments
List of Figures
Figure 1. End-Stage Kidney Disease Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global End-Stage Kidney Disease Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global End-Stage Kidney Disease Market Size Market Share by Treatment (2015-2020)
Figure 5. Global Transplantation Market Size Growth Rate
Figure 6. Global Dialysis Market Size Growth Rate
Figure 7. End-Stage Kidney Disease in Hospital
Figure 8. Global End-Stage Kidney Disease Market: Hospital (2015-2020) ($ Millions)
Figure 9. End-Stage Kidney Disease in Clinic
Figure 10. Global End-Stage Kidney Disease Market: Clinic (2015-2020) ($ Millions)
Figure 11. End-Stage Kidney Disease in Others
Figure 12. Global End-Stage Kidney Disease Market: Others (2015-2020) ($ Millions)
Figure 13. Global Others YoY Growth ($ Millions)
Figure 14. Global End-Stage Kidney Disease Market Size Market Share by End User in 2019
Figure 15. Global End-Stage Kidney Disease Market Size Market Share by Regions 2015-2020
Figure 16. Americas End-Stage Kidney Disease Market Size 2015-2020 ($ Millions)
Figure 17. APAC End-Stage Kidney Disease Market Size 2015-2020 ($ Millions)
Figure 18. Europe End-Stage Kidney Disease Market Size 2015-2020 ($ Millions)
Figure 19. Middle East & Africa End-Stage Kidney Disease Market Size 2015-2020 ($ Millions)
Figure 20. Americas End-Stage Kidney Disease Market Size Market Share by Countries in 2019
Figure 21. Americas End-Stage Kidney Disease Market Size Market Share by Treatment in 2019
Figure 22. Americas End-Stage Kidney Disease Market Size Market Share by End User in 2019
Figure 23. United States End-Stage Kidney Disease Market Size Growth 2015-2020 ($ Millions)
Figure 24. Canada End-Stage Kidney Disease Market Size Growth 2015-2020 ($ Millions)
Figure 25. Mexico End-Stage Kidney Disease Market Size Growth 2015-2020 ($ Millions)
Figure 26. APAC End-Stage Kidney Disease Market Size Market Share by Regions in 2019
Figure 27. APAC End-Stage Kidney Disease Market Size Market Share by Treatment in 2019
Figure 28. APAC End-Stage Kidney Disease Market Size Market Share by End User in 2019
Figure 29. China End-Stage Kidney Disease Market Size Growth 2015-2020 ($ Millions)
Figure 30. Japan End-Stage Kidney Disease Market Size Growth 2015-2020 ($ Millions)
Figure 31. Korea End-Stage Kidney Disease Market Size Growth 2015-2020 ($ Millions)
Figure 32. Southeast Asia End-Stage Kidney Disease Market Size Growth 2015-2020 ($ Millions)
Figure 33. India End-Stage Kidney Disease Market Size Growth 2015-2020 ($ Millions)
Figure 34. Australia End-Stage Kidney Disease Market Size Growth 2015-2020 ($ Millions)
Figure 35. Europe End-Stage Kidney Disease Market Size Market Share by Countries in 2019
Figure 36. Europe End-Stage Kidney Disease Market Size Market Share by Treatment in 2019
Figure 37. Europe End-Stage Kidney Disease Market Size Market Share by End User in 2019
Figure 38. Germany End-Stage Kidney Disease Market Size Growth 2015-2020 ($ Millions)
Figure 39. France End-Stage Kidney Disease Market Size Growth 2015-2020 ($ Millions)
Figure 40. UK End-Stage Kidney Disease Market Size Growth 2015-2020 ($ Millions)
Figure 41. Italy End-Stage Kidney Disease Market Size Growth 2015-2020 ($ Millions)
Figure 42. Russia End-Stage Kidney Disease Market Size Growth 2015-2020 ($ Millions)
Figure 43. Spain End-Stage Kidney Disease Market Size Growth 2015-2020 ($ Millions)
Figure 44. Middle East & Africa End-Stage Kidney Disease Market Size Market Share by Countries in 2019
Figure 45. Middle East & Africa End-Stage Kidney Disease Market Size Market Share by Treatment in 2019
Figure 46. Middle East & Africa End-Stage Kidney Disease Market Size Market Share by End User in 2019
Figure 47. Egypt End-Stage Kidney Disease Market Size Growth 2015-2020 ($ Millions)
Figure 48. South Africa End-Stage Kidney Disease Market Size Growth 2015-2020 ($ Millions)
Figure 49. Israel End-Stage Kidney Disease Market Size Growth 2015-2020 ($ Millions)
Figure 50. Turkey End-Stage Kidney Disease Market Size Growth 2015-2020 ($ Millions)
Figure 51. GCC Countries End-Stage Kidney Disease Market Size Growth 2015-2020 ($ Millions)
Figure 52. Global End-Stage Kidney Disease arket Size Forecast (2021-2025) ($ Millions)
Figure 53. Americas End-Stage Kidney Disease Market Size 2021-2025 ($ Millions)
Figure 54. APAC End-Stage Kidney Disease Market Size 2021-2025 ($ Millions)
Figure 55. Europe End-Stage Kidney Disease Market Size 2021-2025 ($ Millions)
Figure 56. Middle East & Africa End-Stage Kidney Disease Market Size 2021-2025 ($ Millions)
Figure 57. United States End-Stage Kidney Disease Market Size 2021-2025 ($ Millions)
Figure 58. Canada End-Stage Kidney Disease Market Size 2021-2025 ($ Millions)
Figure 59. Mexico End-Stage Kidney Disease Market Size 2021-2025 ($ Millions)
Figure 60. Brazil End-Stage Kidney Disease Market Size 2021-2025 ($ Millions)
Figure 61. China End-Stage Kidney Disease Market Size 2021-2025 ($ Millions)
Figure 62. Japan End-Stage Kidney Disease Market Size 2021-2025 ($ Millions)
Figure 63. Korea End-Stage Kidney Disease Market Size 2021-2025 ($ Millions)
Figure 64. Southeast Asia End-Stage Kidney Disease Market Size 2021-2025 ($ Millions)
Figure 65. India End-Stage Kidney Disease Market Size 2021-2025 ($ Millions)
Figure 66. Australia End-Stage Kidney Disease Market Size 2021-2025 ($ Millions)
Figure 67. Germany End-Stage Kidney Disease Market Size 2021-2025 ($ Millions)
Figure 68. France End-Stage Kidney Disease Market Size 2021-2025 ($ Millions)
Figure 69. UK End-Stage Kidney Disease Market Size 2021-2025 ($ Millions)
Figure 70. Italy End-Stage Kidney Disease Market Size 2021-2025 ($ Millions)
Figure 71. Russia End-Stage Kidney Disease Market Size 2021-2025 ($ Millions)
Figure 72. Spain End-Stage Kidney Disease Market Size 2021-2025 ($ Millions)
Figure 73. Egypt End-Stage Kidney Disease Market Size 2021-2025 ($ Millions)
Figure 74. South Africa End-Stage Kidney Disease Market Size 2021-2025 ($ Millions)
Figure 75. Israel End-Stage Kidney Disease Market Size 2021-2025 ($ Millions)
Figure 76. Turkey End-Stage Kidney Disease Market Size 2021-2025 ($ Millions)
Figure 77. GCC Countries End-Stage Kidney Disease Market Size 2021-2025 ($ Millions)
